UnitedHealth Group is far from the perfect stock, but it is an appealing buy because it can learn from its errors and ...

UnitedHealth Group stock is a top dividend growth stock with solid returns, reliable yield, and long-term growth prospects.

Discover why UnitedHealth stock rebounded after a sharp decline, future growth prospects, and how strategic changes may offer ...

A political battle continues within the U.S. government over renewing expired Affordable Care Act (ACA) subsidies. The ...

UnitedHealth Group shareholders probably want to forget. However, the health insurance giant should see brighter days ahead.

UnitedHealth Group has agreed to sell its last South American business Banmedica to Brazilian private equity group Patria ...

Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” A copy of the letter can be downloaded here. As we move into 2025, the ...

UnitedHealth Group (UNH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

UnitedHealth Group Inc. defeated an insurance reimbursement suit Tuesday after a federal appeals court affirmed the Employee ...

UnitedHealth Group has reached a deal to sell its Latin American business Banmedica for $1 billion, according to media ...

UNH trades below its five-year median P/E as it navigates margin pressure, membership declines and strategic divestments.

Former UnitedHealth Group CEO William McGuire joins mediation team for Fairview and University of Minnesota merger negotiations.